Page last updated: 2024-08-24

cephalosporin c and amikacin

cephalosporin c has been researched along with amikacin in 221 studies

Research

Studies (221)

TimeframeStudies, this research(%)All Research%
pre-199059 (26.70)18.7374
1990's57 (25.79)18.2507
2000's63 (28.51)29.6817
2010's32 (14.48)24.3611
2020's10 (4.52)2.80

Authors

AuthorsStudies
Ichiman, Y; Narikawa, S; Takahashi, M; Usui, Y; Yoshida, K1
George, WL; Lewis, RP; Meyer, RD1
Arbeter, AM; Plotkin, SA1
Kohl, S; Pickering, LK1
Fieker, DH; McHenry, MC1
Granatek, AP; Nunning, BC; Ricci, RA1
Hopefl, AW1
Shah, PM; Stille, W1
Ball, P; Gray, J1
Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M1
Simon, C1
Gayer, J1
McAllister, TA1
Klastersky, J; Meunier-Carpentier, F; Prevost, JM; Staquet, M1
Baert, L1
Kanazawa, Y; Kuramata, T1
Hanberger, H1
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E1
Bailey, EM; Lamp, KC; McGrath, BJ; Rybak, MJ1
Hattori, M; Sampi, K1
Barbhaiya, RH; Knupp, CA; Pfeffer, M; Pittman, KA1
Barbhaiya, RH; Knupp, CA; Papp, EA1
Fung-Tomc, J; Huczko, E; Kessler, RE; Kolek, B; Thater, C1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP1
Cunningham, MD; Darveau, RP1
Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME1
Albayrak, D; Taşdemir, HA1
Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A1
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T1
Boelaert, J; Gordts, B; Lambert, A; Van Landuyt, HW1
Giamarellou, H1
Hohl, P; Kafader, FM; Salfinger, M1
Clavijo, E; García Luque, IG; Nogales, MC; Perea, EJ1
Guenin, K; Herschkowtiz, N; Schaad, UB; Steffen, C1
Durgham, SM; Ishag, AJ; Shibl, AM1
Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M1
Acar, JF; Bleriot, JP; Goldstein, FW; Menard, R1
Gaya, H1
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR2
Van der Auwera, P1
Mitrou, PS; Mondorf, AW; Scherberich, JE; Schoeppe, W; Stefanescu, T1
De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH1
Barriere, SL; Pons, VG; Wilson, CB1
Klastersky, J; Lagast, H; Van Laethem, Y1
Berk, SL; Verghese, A1
Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH1
Murray, PR1
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ1
Chavanet, P; Cortet, P; Guy, H; Kazmierczak, A; Portier, H1
Meyer, RD; Pasiecznik, K1
Bayer, AS; Eisenstadt, R; Morrison, JO1
Gerding, DN; Moody, JA; Peterson, LR1
Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR1
Mirrett, S; Reimer, LG; Reller, LB1
Klesel, N; Limbert, M; Seibert, G1
Hasegawa, S; Nakao, I1
Giamarellou, H; Mavroudis, K; Petrikkos, G; Zissis, N1
Ambrose, PJ; Harralson, AF; Tindula, RJ1
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G1
Durosoir, JL; Meyran, M; Thabaut, A1
Hayashi, A; Iori, F; Mochida, C; Nasu, M; Sawatari, K1
Haas, H; Michel, J; Sacks, TG1
Appleby, DH; John, JF1
Jones, RN; Packer, RR1
Luper, WE; Martin, RF; Phillips, LE; Rogers, TE1
Klastersky, J1
Cappelletty, DM; Kang, SL; Palmer, SM; Rybak, MJ1
Andrea, R; Barnes, HG; Schneider, RK1
Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P1
Bonner, DP; Fung-Tomc, J; Kolek, B1
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M1
Schuler, D1
López, MM; Martín, C; Merino, J; Navarro, V; Roig, PP; Sánchez, B; Zorraquino, A1
Haimann, MH; Miller, J; Weiss, H1
Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D1
Chéron, G; Gaillard, JL; Labenne, M; Lacaille, F; Le Masne, A; Pron, B; Silly, C1
Blesa Sánchez, E; Núñez Núñez, R; Vázquez Rueda, F1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y1
Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Quillard, J; Samii, K; Tod, M1
Bjökholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G1
Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA1
Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C1
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI1
Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M1
Quentin, C; Tessier, F1
Charnas, R; Lüthi, AR; Ruch, W1
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD1
Elkhaïli, H; Jehl, F; Levêque, D; Linger, L; Monteil, H; Niedergang, S; Peter, JD; Pompei, D; Salmon, J; Salmon, Y; Thierry, RC1
Canis, F; Cavallo, JD; Husson, MO1
D'Amico, DT; Ng, EW1
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Bhutta, ZA1
Curati, W; Lynn, WA; McLaughlin, JE; Ogg, G; Peters, M; Shaunak, S1
Eltahawy, AT1
Chiodo, F; Ferri, M; Manfredi, R; Nanetti, A1
Brière, S; Brun-Buisson, C; Petit, C; Schweich, H; Sollet, JP1
Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M1
Jacolot, A; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M1
Bessho, M; Endo, K; Fukuda, M; Hirashima, K; Kawai, N; Kobayashi, Y; Tominaga, K1
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P2
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J1
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM1
Blackshear, P; Branch, S; Chernoff, N; Hall, L1
Castagnola, E; Dini, G; Giacchino, R; Lanino, E; Viscoli, C1
Hubbard, RW; Slocum, R1
Beaucaire, G; Holzapfel, L; Le Fur, D; Léophonte, P; Martin, C; Nicolas, MH; Offenstadt, G; Péan, Y; Philippon, A; Renard, S1
Mayer, I; Nagy, E1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Christodoulou, C; Dellagrammaticas, HD; Kapetanakis, J; Kourakis, G; Megaloyanni, E; Papadimitriou, M1
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D1
Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y1
Bantar, C; Di Chiara, M; Nicola, F; Relloso, S; Smayevsky, J1
Jakoniuk, P; Sacha, PT; Zaremba, ML1
Aebischer, CC; Bettinelli, A; Bianchetti, MG; Truttmann, AC; von Vigier, RO; Wermuth, B; Zindler-Schmocker, K1
Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA1
Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P1
Kushnareva, MV1
Antoniadou, A; Bassaris, HP; Busch, W; Giamarellou, H; Grouzi, E; Petrikkos, G; Voulgarelis, M; Zoumbos, N1
Bansal, AK; Garg, P; Sharma, S; Vemuganti, GK1
Inoue, M; Matsuda, K1
Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R1
Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D1
Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P1
Baron, D; Bugnon, D; Caillon, J; Dube, L; Kergueris, MF; Le Conte, P; Navas, D; Potel, G; Robaux, MA1
Bessho, M; Endo, K; Fukuda, M; Kawai, N; Maesaki, S; Takinami, S; Tominaga, K; Yamazaki, T1
Alvarez-Lerma, F; Barcenilla, F; Insausti-Ordeñana, J; Jordá-Marcos, R; Maraví-Poma, E; Martínez-Pellús, A; Nava, J; Palomar, M; Torres-Martí, A1
Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C1
Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N1
Baran, D; Byl, B; Herschuelz, A; Jacobs, F; Thys, JP1
Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y1
Akan, H; Akova, M; Cetinkaya, Y; Erman, M; Ferhanoğlu, B; Köksal, I; Korten, V; Unal, S; Uzun, O1
Ji, S; Wang, R; Wang, Y1
Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N1
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L1
Hsu, WM; Kao, SC; Kau, HC; Liu, JH; Tsai, CC1
Citak, A; Garratty, G; Karabocuoglu, M; Ucsel, R; Uzel, N1
Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L1
Boukadida, J; Monastiri, K; Salem, N; Seket, B; Snoussi, N; Taher, NB1
de André Júnior, LS; de Resende, MV; Schmidt, ML; Vieira, ML1
Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A1
Barr-Alí, M; Burgaleta, C; De Miguel, D; García-Suárez, J; Hernanz, N; Krsnik, I; Reyes, E1
Dionyssiou-Asteriou, A; Dontas, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Plachouras, D; Raftogiannis, M; Skiathitis, S1
Adriensen, B; Husson, MO; Loiez, C; Massoni-Cristante, S1
Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP1
Borner, K; Brodersen, B; Koeppe, P; Lode, H; Lubasch, A; Ziege, S1
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE1
Derevianko, II1
Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV1
Akiyama, N; Imajo, K; Masaoka, T; Ohyashiki, K; Suzuki, K; Tamura, K; Tanimoto, M; Urabe, A1
Ohyashiki, K1
Chen, TP; Chen, YH; Lu, PL; Peng, CF; Tsai, JJ1
Calabuig, E; Cervera, JI; Sauquillo, JM; Todolí, JA1
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Mouktaroudi, M; Perrea, D1
Ho, SW; Hsueh, PR; Teng, LJ; Tseng, SP1
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A1
Archambaud, M; Chabanon, G; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Saivin, S; Seguin, T; Virenque, C1
Kedzia, WB; Mirska, I1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T1
Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A1
Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL1
Alp, E; Aygen, B; Metan, G; Sumerkan, B1
Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L1
Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ1
Cho, YH; Ha, US; Han, CH; Kim, CS; Kim, ME; Lee, SD; Shim, BS1
Aksaranugraha, S; Kittisomprayoonkul, W; Suankratay, C; Sukonthamarn, K; Tantisiriwat, N; Tantisiriwat, W; Unhasuta, C1
Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE1
Chang, KT; Hou, JG; Kwa, AL; Ledesma, KR; Lim, TP; Nikolaou, M; Prince, RA; Quinn, JP; Tam, VH1
Chaudhary, M; Sehgal, R; Shrivastava, SM; Varughese, L1
Chaudhary, M; Dwivedi, VK; Soni, A1
Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS1
Amicosante, G; Falcone, M; Mancini, C; Mezzatesta, ML; Perilli, M; Stefani, S; Venditti, M1
Conejo, Mdel C; Hernández, JR; Pascual, A1
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L1
Berneman, ZN; Goossens, H; Mebis, J1
Chaudhary, M; Dwivedi, VK; Shrivastava, SM; Singh, CP; Soni, A1
Hou, J; Ledesma, KR; Prince, RA; Singh, R; Tam, VH; Yuan, Z1
Falagas, ME; Gkegkes, ID; Kastoris, AC; Rafailidis, PI; Vouloumanou, EK1
Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S1
Aysev, D; Doğu, F; Erol Cipe, F; Ikincioğulları, A; Sucuoğlu, D1
Boileau, P; Coquery, S; Guibert, M; Traoré, P; Zupan-Simunek, V1
Burd, EM; Ribner, BS; Shak, JR; Whitaker, JA1
Davies, T; Decker-Burgard, S; Körber-Irrgang, B; Kresken, M; Läuffer, J1
Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M1
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P1
Chaumais, MC; Jacolot, A; Judel, C; Louchahi, K; Marchand, S; Mimoz, O; Nicolas, P; Petitjean, O1
Kimura, S; Kitazawa, T; Koga, I; Makita, E; Matsunaga, N; Okugawa, S; Ota, Y; Seo, K; Yoshino, Y1
Elce, YA; Michaud, G; Rodriguez Batista, E; Trencart, P1
Antonopoulos, IM; David-Neto, E; de Paula, FJ; Freire, MP; Guimarães, T; Moura, ML; Nahas, WC; Pierrotti, LC; Piovesan, AC; Spadão, F1
Fischer, AT; Franzen, D; Lamberski, N; Rantanen, NW; Richardson, GL; Zuba, J1
Gentry, CA; Williams, RJ1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N1
Lee, DG; Lee, SH; Lee, Y; Yoo, KH1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A1
Gao, L; Li, Y; Lyu, Y1
Li, B; Li, L; Peters, BM; Shirtliff, ME; Xie, J; Xu, Z; Yu, G1
Chesnel, L; Howland, K; Jacqueline, C1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK1
Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D1
Kidd, JM; Kuti, JL; Nicolau, DP1
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J1
Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR1
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A1
Fernández Esgueva, M; Ferrer Cerón, I; García-Lechuz Moya, JM; López-Calleja, AI; Morilla Morales, E; Nuñez Medina, R; Rezusta López, A; Sahagún Pareja, J; Viñuelas Bayon, J1
Avery, LM; Mullane, EM; Nicolau, DP1
Aitken, SL; Gerges, B; Prince, RA; Raad, I; Rolston, KVI; Shelburne, S1
Adamou, P; Antoniadou, A; Damala, M; Deliolanis, I; Fountoulis, K; Galani, I; Galani, L; Giamarellou, H; Karaiskos, I; Karantani, I; Kirikou, H; Kodonaki, A; Maraki, S; Markopoulou, M; Papadogeorgaki, E; Papoutsaki, V; Petinaki, E; Prifti, E; Souli, M; Tsiplakou, S; Vagiakou, E1
Carvalhaes, CG; Castanheira, M; Doyle, TB; Sader, HS; Streit, JM1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E1
Bonilla, AG; Causeret, L; Torrent-Crosa, A1
Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S1
Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y1
Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jagota, B; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, L; Sharland, M; Unsworth, J1
Jia, P; Xu, Y; Yang, Q; Yu, W; Zhang, H; Zhu, Y1

Reviews

11 review(s) available for cephalosporin c and amikacin

ArticleYear
Recent advances in antimicrobial therapy.
    Southern medical journal, 1977, Volume: 70, Issue:10

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim

1977
Newer antibacterial and antimycotic drugs. Critical appraisal.
    The Medical clinics of North America, 1978, Volume: 62, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim

1978
Empiric therapy of febrile granulocytopenic patients.
    American journal of hospital pharmacy, 1979, Volume: 36, Issue:2

    Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin

1979
Recent advances in antibiotics.
    Scottish medical journal, 1976, Volume: 21, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin

1976
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin

1986
[Retropharyngeal abscess. A report of 3 cases].
    Anales espanoles de pediatria, 1996, Volume: 45, Issue:1

    Topics: Amikacin; Anesthesia, General; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Retropharyngeal Abscess; Streptococcal Infections; Suction

1996
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:12

    Topics: Adult; AIDS-Related Opportunistic Infections; Alcaligenes; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Female; HIV-1; Humans; Male; Respiratory Tract Infections

1997
Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature.
    Ophthalmology, 2001, Volume: 108, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cornea; Cyanoacrylates; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection; Visual Acuity

2001
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2005
Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:4

    Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Pneumonia, Ventilator-Associated; Sisomicin

2018
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin

2021

Trials

41 trial(s) available for cephalosporin c and amikacin

ArticleYear
Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum.
    The Journal of infectious diseases, 1976, Volume: 134, Issue:3

    Topics: Aged; Amikacin; Blood Bactericidal Activity; Cefazolin; Cephalosporins; Drug Evaluation; Drug Synergism; Humans; Kanamycin; Klebsiella; Male; Middle Aged; Species Specificity

1976
[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Piperacillin; Prospective Studies

1992
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    The American journal of medicine, 1982, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin

1982
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections, Intravenous; Lenses, Intraocular; Male; Middle Aged; Postoperative Complications; Risk Factors; Treatment Outcome; Vision, Ocular; Visual Acuity; Vitrectomy

1995
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32 Suppl B

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic

1993
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Revista medica de Chile, 1995, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins

1995
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins

1995
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
    Scandinavian journal of infectious diseases, 1996, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Neutropenia; Trimethoprim, Sulfamethoxazole Drug Combination

1996
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections

1997
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia

1997
Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Consumer Product Safety; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Population; Treatment Failure; Ventilators, Mechanical

1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Annals of hematology, 1998, Volume: 76, Issue:2

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins

1998
[Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome

1998
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
    Leukemia, 1998, Volume: 12, Issue:10

    Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin

1998
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Cancer, 1999, Jan-01, Volume: 85, Issue:1

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome

1999
[Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
    Annales francaises d'anesthesie et de reanimation, 1999, Volume: 18, Issue:2

    Topics: Amikacin; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Survival Rate

1999
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis

2000
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Cancer, 2000, Jun-15, Volume: 88, Issue:12

    Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors

2000
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome

2000
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12

    Topics: Administration, Oral; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome

2000
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Cancer, 2001, Apr-15, Volume: 91, Issue:8

    Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome

2001
[Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Treatment Outcome

2001
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Intensive care medicine, 2001, Volume: 27, Issue:3

    Topics: Aged; Amikacin; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Proportional Hazards Models; Prospective Studies; Spain; Survival Analysis; Treatment Outcome

2001
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey

2001
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:11

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia; Lymphoma, Non-Hodgkin; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome

2001
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2002
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:7

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Cross-Over Studies; Female; Fluoroquinolones; Humans; Male; Naphthyridines

2003
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Cancer, 2003, Sep-01, Volume: 98, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin

2003
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome

2003
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39 Suppl 1

    Topics: Amikacin; Antineoplastic Agents; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Japan; Leukemia; Male; Neutropenia; Opportunistic Infections

2004
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
    International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:8

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Area Under Curve; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome

2005
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:12

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome

2006
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Singapore medical journal, 2007, Volume: 48, Issue:7

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction

2007
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
    Current clinical pharmacology, 2008, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Treatment Outcome

2008
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult

2009
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult

2010
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
    Clinical biochemistry, 2012, Volume: 45, Issue:10-11

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome

2012
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult

2018

Other Studies

169 other study(ies) available for cephalosporin c and amikacin

ArticleYear
[Effect of combination of hetacillin, cephapirin and amikacin (author's transl)].
    The Japanese journal of antibiotics, 1979, Volume: 32, Issue:8

    Topics: Amikacin; Bacteria; Cephalosporins; Cephapirin; Drug Combinations; Drug Synergism; Escherichia coli; Kanamycin; Klebsiella pneumoniae; Penicillin Resistance; Penicillins; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus

1979
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    Antimicrobial agents and chemotherapy, 1978, Volume: 13, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae; Escherichia coli; Klebsiella; Penicillin Resistance; Piperacillin; Proteus; Pseudomonas aeruginosa; Serratia

1978
New antibiotics and old diseases.
    Clinical pediatrics, 1977, Volume: 16, Issue:5

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Humans; Penicillin Resistance; Spectinomycin; Sulfonamides; Tobramycin; Trimethoprim

1977
Physical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions - part III.
    Current therapeutic research, clinical and experimental, 1976, Volume: 20, Issue:4

    Topics: Amikacin; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Incompatibility; Drug Stability; Erythromycin; Injections, Intravenous; Kanamycin; Lincomycin; Novobiocin; Penicillins; Polymyxins; Solutions; Tetracyclines; Time Factors; Vancomycin

1976
[Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Arzneimittel-Forschung, 1978, Volume: 28, Issue:9

    Topics: Amikacin; Bacteria; Bacterial Infections; Cefazolin; Cefoxitin; Cephalosporins; Drug Synergism; Escherichia coli; Humans; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus vulgaris; Time Factors

1978
Activity of cefuroxime, cefoxitin and amikacin against Serratia marcesens.
    The Journal of antimicrobial chemotherapy, 1979, Volume: 5, Issue:4

    Topics: Amikacin; Cefoxitin; Cefuroxime; Cephalosporins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens

1979
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Microbiology and immunology, 1979, Volume: 23, Issue:10

    Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin

1979
[Possible indications for recently developed antibiotics [author's transl)].
    Monatsschrift fur Kinderheilkunde, 1979, Volume: 127, Issue:4

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Kinetics; Netilmicin; Penicillins; Sisomicin

1979
[Therapy of pyelonephritis].
    Deutsche medizinische Wochenschrift (1946), 1977, Jun-03, Volume: 102, Issue:22

    Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Nalidixic Acid; Penicillin Resistance; Pivampicillin; Pyelonephritis; Sulfonamides; Tetracyclines; Tobramycin; Trimethoprim

1977
Bacterial prostatitis treated by local antibiotics.
    Urology, 1976, Volume: 8, Issue:6

    Topics: Amikacin; Bacterial Infections; Cefazolin; Cephalosporins; Follow-Up Studies; Gentamicins; Humans; Injections; Kanamycin; Male; Prostatitis

1976
[Drug sensitivity of Yersinia enterocolitica and Yersinia pseudotuberculosis].
    The Japanese journal of antibiotics, 1976, Volume: 29, Issue:4

    Topics: Amikacin; Animals; Antibiotics, Antitubercular; Cephalosporins; Chloramphenicol; Dogs; Gentamicins; Humans; Kanamycin; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Tetracyclines; Tobramycin; Yersinia

1976
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Scandinavian journal of infectious diseases. Supplementum, 1992, Volume: 81

    Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin

1992
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
    Minerva chirurgica, 1992, Oct-31, Volume: 47, Issue:20

    Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors

1992
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Amikacin; Aztreonam; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Half-Life; Humans; In Vitro Techniques; Pseudomonas Infections

1992
Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7

    Topics: Adult; Amikacin; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Male

1992
High-performance liquid chromatographic assays for the quantification of amikacin in human plasma and urine.
    Journal of chromatography, 1992, Feb-07, Volume: 574, Issue:1

    Topics: Amikacin; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Humans

1992
In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Interactions; Drug Resistance, Microbial; Gram-Negative Bacteria; Microbial Sensitivity Tests

1991
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin

1991
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:4

    Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin

1990
Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:4

    Topics: Amikacin; Blood Bactericidal Activity; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Complement C9; Complement System Proteins; Dose-Response Relationship, Drug; Humans; Imipenem; Lipopolysaccharides; Pseudomonas aeruginosa; Serum Bactericidal Test

1990
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
    The Journal of antibiotics, 1989, Volume: 42, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1989
[Antibiotics used for paratyphi B infections resistant to classical treatment and the results of their use].
    Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:1

    Topics: Amikacin; Ampicillin Resistance; Cefotaxime; Cephalosporins; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Humans; Infant; Paratyphoid Fever; Salmonella; Salmonella paratyphi B; Trimethoprim, Sulfamethoxazole Drug Combination

1989
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
    Lancet (London, England), 1987, Aug-08, Volume: 2, Issue:8554

    Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections

1987
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin

1986
In vitro activity of BRL 36650, a new penicillin.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas aeruginosa

1986
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1987
Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin

1988
Effects of antimicrobial agents used for therapy of CNS infections on dissociated brain cell cultures.
    Pediatric research, 1988, Volume: 24, Issue:3

    Topics: Amikacin; Animals; Animals, Newborn; Anti-Bacterial Agents; Bacterial Infections; Brain; Cell Differentiation; Cell Division; Cells, Cultured; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; DNA; Drug Therapy, Combination; Humans; Penicillin G; Proteins; Rats; Rats, Inbred Strains; Streptomycin

1988
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin

1987
The efficacy of amikacin in the treatment of severe infections in a renal unit.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis

1987
Strategies in aminoglycoside use and impact upon resistance.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Acinetobacter; Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Penicillin Resistance; Pseudomonas; R Factors; Risk; Staphylococcus

1986
Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Agranulocytosis; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Immune Tolerance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus

1986
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:6

    Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa

1985
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:8

    Topics: Amikacin; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1985
Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:5

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Interactions; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Penicillins; Pseudomonas aeruginosa; Quinolines

1985
Elimination of brush border membrane protein in urine caused by toxic alterations of the tubular cell.
    Contributions to nephrology, 1981, Volume: 24

    Topics: Adolescent; Adult; Amikacin; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Cefotaxime; Cell Membrane; Cephalosporins; Cisplatin; Female; Humans; Kidney Tubules, Proximal; Kinetics; Male; Membrane Proteins; Microvilli; Middle Aged; Netilmicin; Sulfonylurea Compounds

1981
Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Neurosurgery, 1982, Volume: 10, Issue:6 Pt 1

    Topics: Amikacin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam

1982
Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cefoperazone; Ceftazidime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Klebsiella pneumoniae; Pseudomonas aeruginosa

1983
Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
    The American journal of medicine, 1983, Volume: 74, Issue:6

    Topics: Agranulocytosis; Amikacin; Cephalosporins; Cephamycins; Drug Therapy, Combination; Humans; Infections; Kanamycin; Moxalactam; Penicillins; Ticarcillin

1983
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6 Suppl A

    Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Mice; Staphylococcus aureus

1980
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin

1980
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin

1980
[Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
    La Nouvelle presse medicale, 1981, Feb-26, Volume: 10, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Kanamycin; Leukemia; Middle Aged

1981
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Diagnostic microbiology and infectious disease, 1983, Volume: 1, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1983
Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:6

    Topics: Amikacin; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Kanamycin; Time Factors

1984
In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacteria; Cephalosporins; Drug Interactions; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa

1984
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
    Infection, 1980, Volume: 8 Suppl 3

    Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin

1980
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin

1980
Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
    The Journal of antibiotics, 1984, Volume: 37, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Kanamycin

1984
[Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    The Japanese journal of antibiotics, 1984, Volume: 37, Issue:9

    Topics: Acute Disease; Adult; Amikacin; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Cephapirin; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged

1984
In vitro and in vivo interactions of recent cephalosporins with gentamicin and amikacin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:3

    Topics: Adult; Aged; Amikacin; Cephalosporins; Drug Interactions; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged

1984
Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
    Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:12

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Interactions; Gentamicins; Humans; Penicillins; Tobramycin

1983
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Pathologie-biologie, 1982, Volume: 30, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin

1982
[Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Pathologie-biologie, 1982, Volume: 30, Issue:6 Pt 2

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa

1982
[Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    The Japanese journal of antibiotics, 1980, Volume: 33, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Escherichia coli; Gentamicins; Haemophilus influenzae; Klebsiella pneumoniae; Minocycline; Penicillin Resistance; Proteus mirabilis; Rolitetracycline; Staphylococcus aureus; Streptococcus

1980
In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Chemotherapy, 1982, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Cephalosporins; Microbial Sensitivity Tests; Mycobacterium

1982
Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
    Nephron, 1982, Volume: 30, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Gentamicins; Microbial Sensitivity Tests; Peritoneal Dialysis; Solutions; Tobramycin

1982
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:6

    Topics: Amikacin; Cephalosporins; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests

1982
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefamandole; Cefoxitin; Cephalosporins; Gentamicins; Humans; Methods; Tobramycin

1981
Treatment and prevention of bacterial infections during cytostatic chemotherapy.
    Acta clinica Belgica, 1981, Volume: 36, Issue:3

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalosporins; Drug Synergism; Granulocytes; Humans; Kanamycin; Neutropenia

1981
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections

1995
Use of antibiotic-impregnated polymethyl methacrylate for treatment of an open radial fracture in a horse.
    Journal of the American Veterinary Medical Association, 1995, Dec-01, Volume: 207, Issue:11

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Bone Screws; Casts, Surgical; Cefazolin; Cephalosporins; Chemotherapy, Adjuvant; Drug Implants; Female; Horses; Methylmethacrylates; Pregnancy; Pregnancy Complications; Radius Fractures; Splints

1995
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6

    Topics: Amikacin; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus

1993
[Bacteremia caused by Capnocytophaga sp: presentation of 2 cases, one with endocarditis. Review of the literature].
    Anales de medicina interna (Madrid, Spain : 1984), 1996, Volume: 13, Issue:4

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male

1996
The Endophthalmitis Vitrectomy Study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Endophthalmitis; Eye Infections, Bacterial; Humans; Lenses, Intraocular; Vitrectomy

1996
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
    Pathologie-biologie, 1996, Volume: 44, Issue:5

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas

1996
[Pneumococcal meningitis in children: should probabilistic antibiotherapy of infectious meningitis be modified?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:5

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Male; Meningitis, Pneumococcal; Netilmicin; Penicillin Resistance; Probability; Retrospective Studies

1996
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin

1996
Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Half-Life; Lung; Multiple Organ Failure; Rats

1996
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries

1996
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin

1996
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar

1997
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1997
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body

1997
[In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Perfusion; Serum Bactericidal Test; Swine; Thienamycins

1997
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin

1997
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Retina (Philadelphia, Pa.), 1997, Volume: 17, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body

1997
Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Interactions; Drug Resistance, Multiple; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1997
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
    The Journal of infection, 1997, Volume: 35, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed

1997
Cerebral nocardia abscesses in a patient with AIDS: correlation of magnetic resonance and white cell scanning images with neuropathological findings.
    The Journal of infection, 1997, Volume: 35, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Magnetic Resonance Imaging; Male; Nocardia asteroides; Nocardia Infections; Radionuclide Imaging; Thienamycins

1997
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries

1997
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Creatinine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Mutant Strains; Time Factors; Treatment Outcome

1998
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:4

    Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E

1998
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:12

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins

1998
Infectious dermatitis in a ball python (Python regius) colony.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 1998, Volume: 29, Issue:4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Cefotaxime; Cephalosporins; Dermatitis; Disease Outbreaks; Fatal Outcome; Female; Male; Proteus Infections; Proteus vulgaris; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious

1998
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1

    Topics: Adolescent; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome

1999
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
    American clinical laboratory, 1995, Volume: 14, Issue:7

    Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin

1995
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas

1999
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar

1999
Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
    Biology of the neonate, 2000, Volume: 77, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Morbidity; Retrospective Studies

2000
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome

2000
Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
    Diagnostic microbiology and infectious disease, 2000, Volume: 37, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2000
[The effect of selected antibacterial antibiotics on production of interferon gamma (IFN-G) by mouse T lymphocytes stimulated by Listeria monocytogenes].
    Medycyna doswiadczalna i mikrobiologia, 1999, Volume: 51, Issue:3-4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cells, Cultured; Cephalosporins; Cephradine; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Listeria monocytogenes; Mice; Penicillins; Rifampin; T-Lymphocytes; Ticarcillin

1999
Aminoglycosides and renal magnesium homeostasis in humans.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Electrolytes; Female; Homeostasis; Humans; Kidney; Lung Diseases; Magnesium; Male; Pseudomonas aeruginosa; Pseudomonas Infections

2000
Impact of n-6 polyunsaturated fatty acids on growth of multidrug-resistant Pseudomonas aeruginosa: interactions with amikacin and ceftazidime.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Multiple; Drug Synergism; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2000
[The effect of netilmicin, amikacin, ceftazidime and cefotaxime on the adhesive properties of microorganisms isolated from newborn infants].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2000, Volume: 45, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Candida albicans; Cefotaxime; Ceftazidime; Cephalosporins; Depression, Chemical; Dose-Response Relationship, Drug; Feces; Gentamicins; Humans; Infant, Newborn; Netilmicin; Respiratory System

2000
[Evaluation of antibiotics by the method of initial bactericidal activity].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

2000
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors

2001
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis

2001
In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits

2001
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:6

    Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping

2001
Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Sputum

2001
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models

2001
[A series of clinical study on netilmicin].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1999, Volume: 22, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Respiratory Tract Infections; Treatment Outcome

1999
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
    Infection control and hospital epidemiology, 2001, Volume: 22, Issue:10

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin

2001
Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii.
    Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:5

    Topics: Acinetobacter; Acinetobacter Infections; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Phacoemulsification; Surgical Wound Infection

2002
Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
    Journal of paediatrics and child health, 2002, Volume: 38, Issue:2

    Topics: Amikacin; Anemia, Hemolytic; Antigen-Antibody Complex; Ceftriaxone; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Methylprednisolone; United States; Urinary Tract Infections

2002
[Initial antibiotic therapy in maternal-fetal infections which include ampicillin even in countries where listeriosis is an incidental disease].
    Bulletin de la Societe de pathologie exotique (1990), 2002, Volume: 95, Issue:2

    Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Protocols; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeriosis; Male; Penicillins; Respiratory Distress Syndrome, Newborn

2002
Multiple embolism in a female patient with infective endocarditis. Low back pain and hematuria as the initial clinical manifestations.
    Arquivos brasileiros de cardiologia, 2002, Volume: 78, Issue:6

    Topics: Amikacin; Ceftriaxone; Cephalosporins; Embolism; Endocarditis, Bacterial; Female; Hematuria; Humans; Low Back Pain; Middle Aged; Mitral Valve Prolapse; Streptococcus; Vancomycin

2002
Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
    British journal of haematology, 2003, Volume: 120, Issue:2

    Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cephalosporins; Chi-Square Distribution; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome

2003
Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Lipid Peroxides; Male; Malondialdehyde; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits; Thiobarbituric Acid Reactive Substances; Time Factors

2003
[Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis].
    Pathologie-biologie, 2003, Volume: 51, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2003
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome

2003
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:7

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sensitivity and Specificity; Treatment Outcome; Urinary Tract Infections

2003
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39 Suppl 1

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis

2004
In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    The Kaohsiung journal of medical sciences, 2004, Volume: 20, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Taiwan

2004
[Endocarditis due to the Neisseria elongata subspecies nitroreducens].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:9

    Topics: Aged; Amikacin; Aorta; Aortic Aneurysm; Aortic Valve; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Neisseria elongata; Neisseriaceae Infections; Species Specificity; Ultrasonography

2004
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: alpha-Linolenic Acid; Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fatty Acids, Unsaturated; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha

2004
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:8

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan

2005
Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Amikacin; Bacillus; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Tobramycin

1989
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins

2006
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics].
    Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin

2006
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan

2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey

2007
Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease.
    International journal of antimicrobial agents, 2008, Volume: 31 Suppl 1

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Korea; Male; Middle Aged; Prostatitis; Retrospective Studies

2008
Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2007, Volume: 90, Issue:11

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Female; Health Status Indicators; Humans; Length of Stay; Male; Prevalence; Red Cross; Rehabilitation Centers; Retrospective Studies; Sickness Impact Profile; Societies, Medical; Spinal Cord Injuries; Thailand; Urinary Tract Infections

2007
Endophthalmitis caused by Bacillus species.
    American journal of ophthalmology, 2008, Volume: 145, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy

2008
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Antagonism; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2008
Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculus mice.
    Current clinical pharmacology, 2008, Volume: 3, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Combinations; Lipid Peroxidation; Liver; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase

2008
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Humans; Integrons; Italy; Male; Meropenem; Plasmids; Proteus Infections; Proteus mirabilis; Surgical Wound Infection; Thienamycins; Treatment Failure; Treatment Outcome

2010
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity

2010
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins

2009
Cefepime and mortality.
    The Lancet. Infectious diseases, 2009, Volume: 9, Issue:10

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Neutropenia

2009
Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection.
    Experimental lung research, 2009, Volume: 35, Issue:7

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pneumonia, Bacterial; Rats; Rats, Wistar; Superoxide Dismutase

2009
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model.
    The Journal of infectious diseases, 2010, Mar-15, Volume: 201, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Lung; Mice; Ofloxacin; Pneumonia, Bacterial; Polymerase Chain Reaction; Pseudomonas aeruginosa; Random Allocation; Survival Analysis

2010
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:4

    Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Methicillin Resistance

2010
Asymptomatic catheter related Rhizobium radiobacter infection in a haploidentical hemapoetic stem cell recipient.
    Journal of infection in developing countries, 2010, Sep-03, Volume: 4, Issue:8

    Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Cefepime; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Severe Combined Immunodeficiency; Stem Cell Transplantation

2010
[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17 Suppl 4

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Treatment Outcome

2010
Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:3

    Topics: Adult; Aeromonas hydrophila; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Fresh Water; Humans; Male; Microbial Sensitivity Tests; Soft Tissue Infections; Tobramycin; Wounds and Injuries

2011
In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Stem Cells; Time Factors

2011
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
    Harefuah, 2010, Volume: 149, Issue:12

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome

2010
Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae.
    Chemotherapy, 2012, Volume: 58, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporinase; Cephalosporins; Cyclophosphamide; Drug Therapy, Combination; Enterobacter cloacae; Immunocompromised Host; Injections, Intraperitoneal; Leukopenia; Male; Models, Animal; Pneumonia, Bacterial; Rats; Rats, Wistar

2012
Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:2

    Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Endocarditis; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Meropenem; Thienamycins; Treatment Outcome

2015
Sterilization by gamma radiation of antibiotic impregnated polymethylmethacrylate and plaster of Paris beads. A pilot study.
    Veterinary and comparative orthopaedics and traumatology : V.C.O.T, 2014, Volume: 27, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Calcium Sulfate; Cephalosporins; Enrofloxacin; Escherichia coli; Fluoroquinolones; Gamma Rays; Microspheres; Pilot Projects; Polymethyl Methacrylate; Pseudomonas aeruginosa; Staphylococcus aureus; Sterilization

2014
Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation.
    Transplantation, 2015, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; beta-Lactamases; Cephalosporins; Child; Cohort Studies; Delayed Graft Function; Enterobacteriaceae Infections; Female; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Risk Factors; Surgical Wound Infection; Time Factors; Tissue Donors; Treatment Outcome; Young Adult

2015
DIAGNOSIS AND MEDICAL AND SURGICAL MANAGEMENT OF CHRONIC INFECTIOUS FIBRINOUS PLEURITIS IN AN OKAPI (OKAPIA JOHNSTONI).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2015, Volume: 46, Issue:2

    Topics: Actinomycetales; Actinomycetales Infections; Amikacin; Animals; Antelopes; Anti-Bacterial Agents; Cephalosporins; Chronic Disease; Female; Penicillin G; Pleurisy; Therapeutic Irrigation

2015
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs

2015
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
    Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection

2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Clinical therapeutics, 2016, Volume: 38, Issue:9

    Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam

2016
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
    Journal of Korean medical science, 2016, Volume: 31, Issue:11

    Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prostatitis; Republic of Korea; Retrospective Studies; Risk Factors

2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
    Nagoya journal of medical science, 2017, Volume: 79, Issue:1

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies

2017
Trends in Drug Resistance of
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2017
Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001-2015.
    Microbial pathogenesis, 2017, Volume: 107

    Topics: Amikacin; Anti-Bacterial Agents; Blood; Carbapenems; Ceftazidime; Cephalosporins; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sputum; Urinary Tract

2017
In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.
    Journal of global antimicrobial resistance, 2017, Volume: 10

    Topics: Amikacin; Aztreonam; Cephalosporins; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Tazobactam; Tigecycline

2017
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1

    Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins

2017
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2018
Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.
    The Journal of antimicrobial chemotherapy, 2018, 09-01, Volume: 73, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Tazobactam

2018
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam

2018
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam

2019
Comparative Evaluation of the
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2020
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
    Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia

2020
In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.
    The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2020
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against
    Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Tazobactam; United States; Whole Genome Sequencing

2021
Pharmacokinetics of ceftiofur in the metacarpophalangeal joint after standing intravenous regional limb perfusion in horses.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2021, Volume: 62, Issue:9

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Forelimb; Horses; Metacarpophalangeal Joint; Perfusion; Synovial Fluid

2021
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin

2022
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
    Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis

2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
    The Journal of antimicrobial chemotherapy, 2022, 11-28, Volume: 77, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Delivery of Health Care; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis

2022
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023